Overview

Phase II Trial of Enbrel in Patients With Primary Systemic Amyloidosis

Status:
Suspended
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of Enbrel in patients with primary systemic Amyloidosis.
Phase:
Phase 2
Details
Lead Sponsor:
The Cleveland Clinic
Treatments:
Etanercept